Theodore DeWeese

Last updated

Theodore L. DeWeese, M.D., is the Francis Watt Baker, M.D. and Lennox D. Baker, M.D. dean of the medical faculty at Johns Hopkins University School of Medicine and the chief executive officer of Johns Hopkins Medicine. [1] He was appointed in December 2023 after serving in an interim capacity for 18 months. [2]

Contents

DeWeese is a professor of oncology and urology at the Johns Hopkins University School of Medicine. His areas of medical expertise include prostate cancer, radiation oncology, urological oncology and DNA damage and repair. [3]

Education and Career

DeWeese, who grew up in Denver, Colorado [4] , received his medical degree from the University of Colorado Health Sciences Center in 1990. He joined The Johns Hopkins Hospital as a radiation oncology resident in 1991 and served as chief resident. In 1994, he completed his residency in radiation oncology, and then undertook a laboratory research fellowship at the Johns Hopkins Oncology Center and the James Buchanan Brady Urological Institute. [3]  In 1995, DeWeese received his board certification in radiation oncology. [5]

DeWeese went on to become the founding director of Johns Hopkins University School of Medicine’s Department of Radiation Oncology and Molecular Radiation Sciences, a role he held for more than 15 years. In 2018, DeWeese became vice dean of clinical affairs and President of the Clinical Practice Association for Johns Hopkins. [6]

DeWeese is a past president of the American Association for Radiation Oncology. [7] In July 2022, following Paul B. Rothman's retirement, DeWeese was appointed interim dean of the Johns Hopkins University School of Medicine and CEO of Johns Hopkins Medicine. In December 2023, he became the 15th dean of the medical faculty and the third CEO of Johns Hopkins Medicine. [5] [8]

Research and Publications

DeWeese has contributed to more than 220 research papers. [9]

Honors and Appointments

DeWeese has served on numerous committees and boards, including as president and chair of the board for the American Society for Radiation Oncology. [10] He has also served on committees for the American Association for Cancer Research and the American Society of Clinical Oncology. DeWeese was also appointed by the National Academy of Sciences as a scientific counselor for the Radiation Effects Research Foundation in Hiroshima, Japan. [11]

DeWeese has received numerous awards and honors, including a Doris Duke Clinical Scientist Award in 1999 for cancer research [12] and two teaching awards from Johns Hopkins, one for teaching clinical science and one for teaching basic science. [3]

Related Research Articles

<span class="mw-page-title-main">Johns Hopkins Hospital</span> Hospital in Maryland, U.S.

The Johns Hopkins Hospital (JHH) is the teaching hospital and biomedical research facility of Johns Hopkins School of Medicine in Baltimore, Maryland. Founded in 1889, Johns Hopkins Hospital and its school of medicine are considered to be the founding institutions of modern American medicine and the birthplace of numerous famed medical traditions, including rounds, residents, and house staff. Several medical specialties were founded at the hospital, including neurosurgery by Harvey Cushing and Walter Dandy, cardiac surgery by Alfred Blalock and Vivien Thomas, and child psychiatry by Leo Kanner. Johns Hopkins Children's Center, which serves infants, children, teens, and young adults aged 0–21, is attached to the hospital.

<span class="mw-page-title-main">MD Anderson Cancer Center</span> Hospital in Texas, United States of America

The University of Texas MD Anderson Cancer Center is a comprehensive cancer center in Houston, Texas. It is the largest cancer center in the world and one of the original three NCI-designated comprehensive cancer centers in the country. It is both a degree-granting academic institution and a cancer treatment and research center located within Texas Medical Center (TMC), Houston, the largest medical center and life sciences destination in the world. MD Anderson Cancer Center has consistently ranked #1 among the best hospitals for cancer care and research in the U.S. and worldwide, and it has held the #1 position 20 times in the last 23 years in U.S. News & World Report's Best Hospitals rankings for cancer care. As of 2023, MD Anderson Cancer Center is home to the highest number of cancer clinical trials in the world and has received more NCI-funded projects than any other U.S. institute. In 2024, Newsweek placed MD Anderson at #1 in their annual list of the World's Best Specialized Hospitals in oncology.

<span class="mw-page-title-main">Johns Hopkins School of Medicine</span> Medical school of Johns Hopkins University

The Johns Hopkins University School of Medicine (JHUSOM) is the medical school of Johns Hopkins University, a private research university in Baltimore, Maryland. Founded in 1893, the School of Medicine shares a campus with Johns Hopkins Hospital and Johns Hopkins Children's Center, established in 1889.

<span class="mw-page-title-main">Cooper University Hospital</span> Hospital in U.S., US

Cooper University Hospital is a teaching hospital and biomedical research facility located in Camden, New Jersey. The hospital formerly served as a clinical campus of Robert Wood Johnson Medical School and the University of Medicine and Dentistry of New Jersey.

<span class="mw-page-title-main">David Geffen School of Medicine at UCLA</span> Medical school of UCLA

The University of California, Los Angeles School of Medicine, also known as the David Geffen School of Medicine at UCLA (DGSOM), is an accredited medical school located in Los Angeles, California, United States. Founded in 1951, it is the second medical school in the University of California system, after the UCSF School of Medicine. The school was renamed in 2001 in honor of media mogul David Geffen who donated $200 million in unrestricted funds.

<span class="mw-page-title-main">Weill Cornell Medicine</span> Medical school of Cornell University

The Joan & Sanford I. Weill Medical College of Cornell University is Cornell University's biomedical research unit and medical school in New York City.

<span class="mw-page-title-main">Stephen Hahn</span> American physician (born 1960)

Stephen Michael Hahn is an American physician who served as the commissioner of food and drugs from 2019 to 2021. Before becoming commissioner, he was an oncologist serving as chief medical executive of the MD Anderson Cancer Center. In 2021, he became chief medical officer at Flagship Pioneering, the venture capital firm that launched Moderna.

Jeffrey R. Balser is the president and CEO of Vanderbilt University Medical Center (VUMC) and dean of the Vanderbilt University School of Medicine (VUSM). Balser is a 1990 graduate of the Vanderbilt M.D./Ph.D. program in pharmacology and subsequently completed residency training in anesthesiology and fellowship training in critical care medicine at Johns Hopkins. He continued to work at Johns Hopkins as a cardiac anesthesiologist and ICU physician before returning to Vanderbilt University and joining VUMC in 1998. Balser was appointed dean of the VUSM in 2008 and, the following year, was appointed the vice chancellor for health affairs at Vanderbilt, in charge of the medical center. He became president and CEO of VUMC in 2016 when the medical center became a financially distinct non-profit organization.

<span class="mw-page-title-main">John E. Niederhuber</span>

John E. Niederhuber was the 13th director of the National Cancer Institute (NCI), from 2006 until July, 2010, succeeding Andrew von Eschenbach, who went on to become a director at biotechnology firm BioTime. A nationally renowned surgeon and researcher, Dr. Niederhuber has dedicated his four-decade career to the treatment and study of cancer - as a professor, cancer center director, National Cancer Advisory Board chair, external advisor to the NCI, grant reviewer, and laboratory investigator supported by NCI and the National Institutes of Health. He is now Executive Vice President/CEO Inova Translational Medicine Institute and Inova Health System and co-director, Johns Hopkins Clinical Research Network.

Minesh P. Mehta is an American radiation oncologist and physician-scientist of Indian origin and Ugandan birth. He is currently deputy director and chief of radiation oncology at Miami Cancer Institute at Baptist Health South Florida.

<span class="mw-page-title-main">David Gorski</span> Science-based medicine advocate

David Henry Gorski is an American surgical oncologist and professor of surgery at Wayne State University School of Medicine. He specializes in breast cancer surgery at the Karmanos Cancer Institute. Gorski is an outspoken skeptic and critic of alternative medicine and the anti-vaccination movement. A prolific blogger, he writes as Orac at Respectful Insolence, and as himself at Science-Based Medicine where he is the managing editor.

<span class="mw-page-title-main">Paul B. Rothman</span>

Paul B. Rothman is the former Frances Watt Baker, M.D., and Lenox D. Baker Jr., M.D., Dean of the Medical Faculty, vice president for medicine at Johns Hopkins University, and former chief executive officer of Johns Hopkins Medicine. As dean and CEO, Rothman oversaw both the School of Medicine and the Johns Hopkins Health System, which together encompass six hospitals, hundreds of faculty and community physicians and a self-funded health plan.

Walter "Wally" J. Curran, Jr. is an American radiation oncologist specializing in the treatment of malignant brain tumors and locally advanced lung cancer.

<span class="mw-page-title-main">Elizabeth Jaffee</span> American oncologist

Elizabeth M. Jaffee is an American oncologist specializing in pancreatic cancer and immunotherapy.

Edward C. Halperin, is the chancellor and CEO of New York Medical College (NYMC) where he is also a professor of radiation medicine, pediatrics and history. He also serves as the Miriam Popack Chair in Biomedical Ethics and director of the Hirth and Samowitz Center for Medical Humanities and Holocaust Studies at NYMC, director of bioethics in the School of Health Sciences and Practice at NYMC, as well as provost for biomedical affairs for the Touro College and University System, a position he has held since 2012.

<span class="mw-page-title-main">Jonathan S. Lewin</span> American neuroradiologist

Jonathan S. Lewin is an American neuroradiologist specializing in medical imaging research with an emphasis on the investigation, development, and translation of new magnetic resonance imaging (MRI) techniques. He is the former executive vice president for health affairs (EVPHA) and executive director of the Woodruff Health Sciences Center for Emory University, and former President, CEO, and chairman of the board of Emory Healthcare. He currently serves as professor of radiology, biomedical engineering, and neurosurgery in the Emory School of Medicine and as professor of health policy and management in the Rollins School of Public Health.

<span class="mw-page-title-main">Nancy J. Tarbell</span> Professor of Radiation Oncology

Nancy Jane Tarbell is the C.C. Wang Professor of Radiation Oncology at Harvard Medical School and Massachusetts General Hospital. Previously, she was the Dean for Academic and Clinical Affairs at Harvard Medical School (2008–2019).

Matthew E. Nielsen is an American urologist oncologist and health services researcher. He is a Full professor and Chair of Urology at the UNC School of Medicine. Nielsen joined the faculty at UNC in 2009 as a urologic oncologist and health services researcher after completing medical school and residency training at Johns Hopkins.

<span class="mw-page-title-main">Reshma Jagsi</span> American radiation oncologist

Reshma Jagsi is an American Radiation oncologist. She is the Lawrence W. Davis Professor and Chair in the Department of Radiation Oncology and Senior Faculty Fellow in the Center for Ethics at Emory University. Overall, she is the author of over 450 published articles in peer-reviewed medical journals and continues scholarly research in three primary areas of interest: breast cancer, bioethics, and gender equity, with the support of grants from the National Institutes of Health (NIH), the Doris Duke Charitable Foundation, and the Susan G. Komen Foundation, for which she serves as a Senior Scholar.

Alan Wayne Partin was an American prostate surgeon and researcher. He was the Jakurski Family Director of the Brady Urological Institute, Urologist-In-Chief of Johns Hopkins School of Medicine, and professor of Urology, Pathology, and Oncology. In 1993, he developed the PartinTables to help prostate cancer patients get an accurate prediction of their likelihood of being cured.

References

  1. ↑ "Theodore DeWeese welcomed as next dean and CEO OF Johns Hopkins Medicine". Office of Communications. Johns Hopkins University. December 20, 2023. Retrieved December 26, 2023.
  2. ↑ "Johns Hopkins University names new CEO of Hopkins Medicine and dean of School of Medicine". Baltimore Sun. 2023-12-08. Retrieved 2024-07-26.
  3. 1 2 3 "Dr. Theodore DeWeese, MD - Baltimore, MD - Radiation Oncology - Schedule an Appointment". profiles.hopkinsmedicine.org. Retrieved 2024-07-26.
  4. ↑ Worthington, Aliza (2023-12-08). "JHU appoints new medical school dean, Johns Hopkins Medicine CEO". Baltimore Fishbowl. Retrieved 2023-12-25.
  5. 1 2 "Theodore DeWeese appointed next dean and CEO of Johns Hopkins Medicine". The Hub. 2023-12-08. Retrieved 2024-07-26.
  6. ↑ "DeWeese Appointed to Top Spot". 2024-02-02. Retrieved 2024-07-26.
  7. ↑ "Theodore Leslie DeWeese, M.D., Professor of Radiation Oncology and Molecular Radiation Sciences". Johns Hopkins Medicine. Retrieved 2023-12-25.
  8. ↑ Staff, Daily Record (2023-12-18). "DeWeese appointed 3rd CEO of Johns Hopkins Medicine". Maryland Daily Record. Retrieved 2024-07-26.
  9. ↑ "DeWeese T - Search Results - PubMed". PubMed. Retrieved 2024-07-26.
  10. ↑ "ASTRO Leadership on D&I - About ASTRO - American Society for Radiation Oncology (ASTRO) - American Society for Radiation Oncology (ASTRO)". ASTRO. Retrieved 2024-07-26.
  11. ↑ Stewardship; Baltimore, Donor Engagement 3400 North Charles Street; MD 21218Development; Relations, Alumni (2016-07-28). "Theodore L. DeWeese - Named Deanships, Directorships, and Professorships" . Retrieved 2024-07-26.{{cite web}}: CS1 maint: numeric names: authors list (link)
  12. ↑ "1999 Clinical Scientist Award". www.dorisduke.org. Retrieved 2024-07-26.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.